ENSURE-AF Trial Supports Edoxaban for Electrical Cardioversion
ROME — Results of the largest-ever randomized clinical trial of anticoagulation for electrical cardioversion of patients with nonvalvular atrial fibrillation demonstrate that edoxaban is a safe, effective, and convenient alternative to the standard strategy of enoxaparin as a bridge to warfarin.
Publication date: March–April 2020Source: Heart &Lung, Volume 49, Issue 2Author(s): Qi An, Viktoria Averina, John Boehmer, George Mark, Pramodsingh Thakur
Publication date: March–April 2020Source: Heart &Lung, Volume 49, Issue 2Author(s): Ryan Ahmed, Michelle Drouin, Elizabeth Martin, Michael Mirro, Romisa Rohani Ghahari, Tammy Toscos
This review provides insights into the complex pathophysiological mechanisms of atrial fibrosis and its relationship with atrial fibrillation.Europace
(American College of Cardiology) Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement (TAVR) had a lower rate of bleeding complications without an increased risk of clotting-related complications compared to patients who took antiplatelet medication in addition to oral anticoagulants, in a trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).
ConclusionsThese three NOAC strategies may have similar safety and efficacy in terms of thromboembolism and major bleeding complications. The total bleeding risk of completely interrupted oral anticoagulants is higher than that of uninterrupted and minimally interrupted NOACs. For thromboembolism, minimally interrupted NOACs, uninterrupted NOACs and continuous VKAs were better than interrupted warfarin.
Publication date: Available online 26 March 2020Source: The Annals of Thoracic SurgeryAuthor(s): Murat Kadan, Kubilay Karabacak, Cengiz Bolcal
In this study, we review various types of AF, proposed mechanisms, and treatment strategies for athletes with AF.
Int J Angiol DOI: 10.1055/s-0040-1705111Atrial fibrillation is a common arrhythmia which may cause symptoms that significantly impact quality of life and is associated with increased risk of stroke, heart failure, and sudden death. Over the past three decades many surgical techniques as well as catheter-bases procedures have been developed to treat atrial fibrillation. In this review we describe the indications, treatments, outcomes, surgical techniques, and technical advances reported in the literature. [...] Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.Article in Thieme eJournals: Table of conten...
Int J Angiol DOI: 10.1055/s-0040-1705153Atrial fibrillation (AF) is a disorganized tachyarrhythmia with significant public health importance due to high morbidity, mortality, and health-care costs. Incidence rate of AF is on the rise and there are several modifiable and nonmodifiable risk factors that are responsible. Exact mechanisms and pathogenesis of AF are still poorly understood, yet they still have great implications in management. The aim of this article is to summarize the epidemiology, major risk factors, and their role in the pathogenesis of AF. Finally, we have reviewed the classification of AF as per professio...
Publication date: Available online 27 March 2020Source: Nutrition, Metabolism and Cardiovascular DiseasesAuthor(s): Alvaro Alonso, Mary R. Rooney, Lin Yee Chen, Faye L. Norby, Amy K. Saenger, Elsayed Z. Soliman, Wesley T. O’Neal, Katie C. Hootman, Elizabeth Selvin, Pamela L. Lutsey